Page last updated: 2024-08-22

yttrium and 68ga-dotanoc

yttrium has been researched along with 68ga-dotanoc in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bagni, O; Cianni, R; Filippi, L; Pelle, G; Salvatori, R; Schillaci, O; Scopinaro, F	1

Other Studies

1 other study(ies) available for yttrium and 68ga-dotanoc

Article	Year
Molecular response assessed by (68)Ga-DOTANOC and survival after (90)Y microsphere therapy in patients with liver metastases from neuroendocrine tumours. European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:3 Topics: Aged; Biomarkers, Tumor; Cohort Studies; Disease-Free Survival; Embolization, Therapeutic; Female; Gallium Radioisotopes; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Microspheres; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome; Yttrium	2016

Article

Year

Molecular response assessed by (68)Ga-DOTANOC and survival after (90)Y microsphere therapy in patients with liver metastases from neuroendocrine tumours.

European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:3

Topics: Aged; Biomarkers, Tumor; Cohort Studies; Disease-Free Survival; Embolization, Therapeutic; Female; Gallium Radioisotopes; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Microspheres; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome; Yttrium

2016